AVIDAS PHARMACEUTICALS LLC – Trademark Portfolio
Entity Type: 16
AVIDAS PHARMACEUTICALS LLC holds 24 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 17 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 3 Nice Classification classes. Currently, 11 trademarks are registered. Notable registered marks include PRO-D3, ROSAGE, FORTEMAN, TRANSEPI, and EPIPHASIC. The owner is based in Doylestown, PA.
196 West Ashland Street
Doylestown, PA 18901
Showing of trademarks Trademarks
Trademark Classifications
AVIDAS PHARMACEUTICALS LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does AVIDAS PHARMACEUTICALS LLC have?
AVIDAS PHARMACEUTICALS LLC has 24 U.S. trademarks filed with the USPTO. Of these, 11 registered, 9 abandoned, 4 cancelled.
What trademark classes does AVIDAS PHARMACEUTICALS LLC file in?
AVIDAS PHARMACEUTICALS LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 35 (Advertising & Business). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are AVIDAS PHARMACEUTICALS LLC's most well-known trademarks?
AVIDAS PHARMACEUTICALS LLC's registered trademark portfolio includes well-known marks such as PRO-D3, ROSAGE, FORTEMAN, TRANSEPI, and EPIPHASIC. These are among 11 currently registered trademarks in the portfolio.
What is AVIDAS PHARMACEUTICALS LLC's trademark registration success rate?
AVIDAS PHARMACEUTICALS LLC has a 46% trademark registration rate, with 11 out of 24 resolved applications resulting in successful registration. Currently, 0 applications are pending review.